跳至主要内容
临床试验/IRCT138807271760N3
IRCT138807271760N3已完成3 期

Effect of Flutamide and Metformin administered in dieting overweight-obese women with polycystic ovary syndrome

Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Reproductive age (range 18-45 yr), body mass index (BMI) at least 28 kg/m2, and waist circumference at least 88 cm, chronic an ovulation severe oligomorrhea or amenorrhea, hirsutism (Ferriman – Gallwey score 8), total testosterone levels at least 0.72 ng/ml and polycystic ovarian morphology at ultrasound. Exclusion criteria: Use of any medication or a significant modification in body weight within the previous 3 months or dieting, hyperprolactinemia, cushing’s syndrome, late–onset congenital adrenal hyperplasia, thyroid dysfunction, diabetes, cardiovascular, renal or Liver diseases, positive pregnancy test.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology, Babol University of Medical Sciences

相似试验